Complete Freund”s adjuvant treatment suppresses IL-17 production in a population of myeloid cells in nonobese diabetic mice
Some reports recently have shown that Th17 cells,as a distinct lineage from Th1 and Th2 subsets,play an obligatory role in autoimmune diabetes.It is well known that immunotherapy with Complete Freund”s adjuvant(CFA) is effective in preventing from the onset of diabetes in nonobese diabetic(NOD) mice.In the present study,we investigated whether CFA treatment restrains Th17 development and down-regulates Th17-related cytokine production in NOD mice.
Xiaogang Gao Guoshan Ding Zhengxin Wang Hong Fu Zhijia Ni Jun Ma Fang Liu Zhiren Fu
Organ Transplantation Center,Changzheng Hospital,Second Military Medical University,Shanghai 200003,People”s Republic of China
国内会议
成都
英文
88-89
2011-06-17(万方平台首次上网日期,不代表论文的发表时间)